# Continuous Hemodynamic Monitoring and Goal-Directed Therapy for Optimization in Total Knee Replacement: A Prospective Observational Study

**Authors:** Christos Christofis, Martha Kyriakou, Alexandra Arvanitaki, Konstantinos Tilkeridis, Kostas Kazakos, Theodosia Vogiatzaki, Chloropoulou Pelagia

PMC · DOI: 10.7759/cureus.98605 · Cureus · 2025-12-06

## TL;DR

This study shows that using continuous hemodynamic monitoring during knee replacement surgery can reduce fluid use and improve recovery.

## Contribution

The novel use of non-invasive ClearSight monitoring for goal-directed therapy in TKA surgery is evaluated.

## Key findings

- GDT group received less intraoperative crystalloid volume than controls.
- GDT group had shorter post-anesthesia care unit stay and more stable blood pressure.
- Findings suggest improved fluid optimization and recovery with GDT.

## Abstract

Goal-directed fluid therapy (GDT) has become an important strategy for optimizing perioperative hemodynamics by tailoring fluid administration to each patient’s individual needs. In this prospective observational study, we evaluated the use of GDT guided by the non-invasive ClearSight monitoring system (Edwards Lifesciences Corporation, Irvine, CA, USA) in patients undergoing total knee arthroplasty (TKA) under spinal anesthesia. Forty patients were included and managed either with a GDT protocol or with standard fluid therapy. Hemodynamic parameters, fluid administration, and early postoperative outcomes were assessed. Patients in the GDT group received significantly less intraoperative crystalloid volume compared to controls and had a shorter stay in the post-anesthesia care unit. Moreover, the GDT group demonstrated more stable mean arterial pressure throughout the procedure. These findings suggest that continuous non-invasive hemodynamic monitoring can enhance intraoperative fluid optimization and improve immediate recovery following orthopedic surgery. Larger randomized trials are necessary to confirm these results and further define the clinical benefits of GDT in this setting.

## Full-text entities

- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12773647/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12773647/full.md

## References

13 references — full list in the complete paper: https://tomesphere.com/paper/PMC12773647/full.md

---
Source: https://tomesphere.com/paper/PMC12773647